Yousif Capital Management LLC decreased its position in Avantor, Inc. (NYSE:AVTR – Free Report) by 1.3% in the second quarter, Holdings Channel.com reports. The firm owned 209,151 shares of the company’s stock after selling 2,770 shares during the quarter. Yousif Capital Management LLC’s holdings in Avantor were worth $2,815,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in AVTR. GAMMA Investing LLC raised its holdings in Avantor by 121.6% in the first quarter. GAMMA Investing LLC now owns 3,747 shares of the company’s stock worth $61,000 after purchasing an additional 2,056 shares in the last quarter. SG Americas Securities LLC raised its holdings in Avantor by 55.1% in the first quarter. SG Americas Securities LLC now owns 36,099 shares of the company’s stock worth $585,000 after purchasing an additional 12,818 shares in the last quarter. Assenagon Asset Management S.A. raised its holdings in Avantor by 5.8% in the first quarter. Assenagon Asset Management S.A. now owns 38,285 shares of the company’s stock worth $621,000 after purchasing an additional 2,108 shares in the last quarter. Fifth Third Bancorp raised its holdings in Avantor by 52.0% in the first quarter. Fifth Third Bancorp now owns 3,972 shares of the company’s stock worth $64,000 after purchasing an additional 1,359 shares in the last quarter. Finally, Dynamic Advisor Solutions LLC raised its holdings in Avantor by 43.9% in the first quarter. Dynamic Advisor Solutions LLC now owns 34,186 shares of the company’s stock worth $554,000 after purchasing an additional 10,433 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.
Avantor Stock Up 5.1%
AVTR stock opened at $14.58 on Friday. Avantor, Inc. has a 1-year low of $10.82 and a 1-year high of $26.14. The business has a fifty day moving average price of $13.00 and a 200-day moving average price of $13.37. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.98 and a quick ratio of 0.67. The stock has a market capitalization of $9.94 billion, a P/E ratio of 14.73, a P/E/G ratio of 4.52 and a beta of 0.98.
Insider Activity at Avantor
In related news, CAO Steven W. Eck sold 3,476 shares of Avantor stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total value of $39,591.64. Following the completion of the sale, the chief accounting officer owned 55,068 shares of the company’s stock, valued at $627,224.52. The trade was a 5.94% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.20% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on AVTR shares. Jefferies Financial Group reiterated a “hold” rating on shares of Avantor in a report on Friday, August 1st. Royal Bank Of Canada lowered their price objective on Avantor from $20.00 to $17.00 and set an “outperform” rating for the company in a research note on Monday, August 4th. Evercore ISI lowered their price objective on Avantor from $18.00 to $16.00 and set an “outperform” rating for the company in a research note on Monday, August 4th. Barclays lifted their price objective on Avantor from $13.00 to $15.00 and gave the company an “overweight” rating in a research note on Thursday, October 2nd. Finally, Morgan Stanley lowered their price objective on Avantor from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, Avantor has a consensus rating of “Hold” and a consensus price target of $15.81.
Get Our Latest Stock Analysis on AVTR
Avantor Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Further Reading
- Five stocks we like better than Avantor
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Salesforce’s Long-Awaited Inflection is Here: Rally On!
- 3 Monster Growth Stocks to Buy Now
- Rocket Lab USA Receives Wall Street Validation: Time to Buy?
- How is Compound Interest Calculated?
- Archer Buys Rival’s Patent Treasure Trove in Strategic Move
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.